🔎 Trials Near Me

Početna › Difuzni veliki B-stanični limfom › Oregon › Portland

Kliničke studije za Difuzni veliki B-stanični limfom u gradu Portland, OR

15 studija za Difuzni veliki B-stanični limfom traži sudionike na lokacijama u gradu Portland i okolici (unutar oko 30 milja). Otvorite studiju da biste vidjeli tko se može priključiti i kako kontaktirati tim studije.

Službeni tekst studije (engleski)

Tražite sudionike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

U tijeku regrutacijaFaza 2
  • Oregon Health and Science University, Portland
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT06500273

Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma

U tijeku regrutacijaFaza 2
  • Providence Portland Medical Center, Portland
  • Providence Saint Vincent Medical Center, Portland
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT06649812

A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

U tijeku regrutacijaFaza 2
  • Providence Portland Medical Center ( Site 0120), Portland
  • Providence Oncology and Hematology Clinic Westside ( Site 0179), Portland
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT06890884

Vaccine Responses in Patient With Multiple Myeloma and Non-Hodgkin Lymphoma After CAR-T Treatment

U tijeku regrutacijaOpažajna studija
  • OHSU Knight Cancer Institute, Portland
Od 18 godina i više · Oba spola · Ažurirano 23. ruj 2026. · NCT06784167

A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

U tijeku regrutacijaFaza 1
  • Oregon Health & Science University (OHSU), Portland
Od 18 godina i više · Oba spola · Ažurirano 22. ruj 2026. · NCT07226843

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

U tijeku regrutacijaFaza 1/2
  • Oregon Health and Science University ( Site 1004), Portland
6 Months – 25 Years · Oba spola · Ažurirano 17. ruj 2026. · NCT06395103

Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL

U tijeku regrutacijaFaza 2
  • Providence Portland Medical Center, Portland
  • Providence St. Vincent Medical Center, Portland
Od 18 godina i više · Oba spola · Ažurirano 11. ruj 2026. · NCT06806033

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

U tijeku regrutacijaFaza 1/2
  • Oregon Health & Science University, Portland
Od 13 do 90 godina · Oba spola · Ažurirano 6. kol 2026. · NCT06533579

Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU

U tijeku regrutacijaOpažajna studija
  • Oregon Health and Science University Knight Cancer Institute, Portland
Od 18 godina i više · Oba spola · Ažurirano 5. kol 2026. · NCT06116110

DALY II USA/ MB-CART2019.1 for DLBCL

U tijeku regrutacijaFaza 2
  • Oregon Health and Science University Knight Cancer Institute, Portland
Od 18 godina i više · Oba spola · Ažurirano 13. srp 2026. · NCT04792489

Mosunetuzumab With Chemotherapy for the Treatment of Patients With Untreated C-Myc Rearrangement Positive High Grade B Cell Lymphoma or Diffuse Large B Cell Lymphoma

U tijeku regrutacijaFaza 1/2
  • OHSU Knight Cancer Institute, Portland
Od 18 do 75 godina · Oba spola · Ažurirano 7. srp 2026. · NCT06249191

Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

U tijeku regrutacijaFaza 2
  • Providence Portland Medical Center, Portland
  • Providence Saint Vincent Medical Center, Portland
  • Oregon Health and Science University, Portland
  • i još 1
Od 18 godina i više · Oba spola · Ažurirano 2. velj 2026. · NCT05633615

Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment

U tijeku regrutacijaFaza 2
  • Providence Portland Medical Center, Portland
  • Providence Saint Vincent Medical Center, Portland
  • Providence Willamette Falls Medical Center, Oregon City · 12 mi udaljenosti
Od 18 godina i više · Oba spola · Ažurirano 20. lis 2025. · NCT05890352

A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies

U tijeku regrutacijaFaza 1
  • Oregon Health & Science University, Portland
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2025. · NCT05780034

Studije za Difuzni veliki B-stanični limfom u drugim gradovima

Ostale studije u gradu Portland

Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.